L. Duan et al. / Tetrahedron Letters 49 (2008) 6624–6627
6627
Yao, S. Z.; Deng, G. H.; He, D. L.; Kuang, Y. F. Anal. Biochem. 2005, 339, 29; (c)
Houze, P.; Gamra, S.; Madelaine, I.; Bousquet, B.; Gourmel, B. J. Clin. Lab. Anal.
2001, 15, 144.
collected by filtration and washed with water. Crystallization from acetic acid
gave 4 as yellow needles: 3.42 g (98.8%), mp 210.5–211.2 °C, IR (KBr) v: 3460,
3370, 1700, 1650, 1630, 1560, 1420, 1280, 1150, 1030. 1H NMR (CDCl3,
400 MHz) d 0.975 (t, J = 7.2 Hz, 3H), 1.43–1.45 (m, 2H), 1.70–1.75 (m, 2H), 4.14
(t, J = 7.2 Hz, 2H), 6.20–6.40 (br s, 2H), 6.85 (d, J = 8.0 Hz, 1H), 7.85 (d, J = 8.0 Hz,
1H), 8.34 (d, J = 8 Hz, 1H), 8.42 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 100 MHz) d
13.83, 20.38, 30.15, 40.12, 112.12, 112.16, 117.52, 122.74, 125.46, 131.56,
131.79, 132.49, 134.23, 150.52, 163.61, 164.01, MS (ESI+) C16H15BrN2O2
[M+H+]: 374.0.
9. (a) Amarnath, K.; Amarnath, V.; Valentine, H. L.; Valentine, W. M. Talanta 2003,
60, 1229; (b) Chwatko, G.; Bald, E. J. Chromatogr. A 2002, 949, 141.
10. Daskalakis, I.; Lucock, M. D.; Anderson, A.; Wild, J.; Schorah, C. J.; Levene, M. I.
Biomed. Chromatogr. 1996, 12, 205.
11. Sato, Y.; Iwata, T.; Tokutomi, S.; Kandori, H. J. Am. Chem. Soc. 2005, 127, 1088.
12. Wang, H.; Wang, W.; Zhang, H. Talanta 2001, 53, 1015.
13. Burford, N.; Eelman, M. D.; Mahony, D. E.; Morash, M. Chem. Commun. 2003, 2,
146.
21. Preparation of N-butyl-4-bromo-5-iodo-1.8-naphthalimide (4): 30 mL of NaNO2
(1.6 g, 0.023 mmol) aqueous solution was added dropwise to the HCl (22%,
25 mL) aqueous solution of 3 (3.5 g, 0.01 mol) at 0 °C. The reaction mixture was
stirred for 2 h at this temperature. The resulting precipitate was added to
40 mL of KI (8.85 g, 0.05 mol) aqueous solution and the mixture reacted for 1 h,
after which NaHSO3 was added to destroy excessive I2. The resulted solid was
collected by filtration and then purified by column chromatography (SiO2,
CHCl3) to give (5) as a white solid in 60% yield (2.7 g), mp 165.1–166.4 °C, IR
14. (a) Anzenbacher, P., Jr.; Try, A. C.; Miyaji, H.; Jursikova, K.; Lynch, V. M.;
Marquez, M.; Sessler, J. L. J. Am. Chem. Soc. 2000, 122, 10268; (b) Miyaji, H.;
Sessler, J. L. Angew. Chem., Int. Ed. 2001, 40, 154; (c) Miyaji, H.; Sato, W.; Sessler,
J. L. Angew. Chem., Int. Ed. 2000, 39, 1777; (d) Xu, S.; Chen, K.; Tian, H. J. Mater.
Chem. 2005, 15, 2676; (e) Han, M. S.; Kim, D. H. Tetrahedron 2004, 60, 11251; (f)
Li, S.; Yu, C.; Xu, J. Chem. Commun. 2005, 450.
15. (a) Rusin, O.; Luce, N. N. S.; Agbaria, R. A.; Escobedo, J. O.; Jiang, S.; Warner, I.
M.; Dawan, F. B.; Lian, K.; Strongin, R. M. J. Am. Chem. Soc. 2004, 126, 438; (b)
Wang, W. H.; Escobedo, J. O.; Lawrence, C. M.; Strongin, R. M. J. Am. Chem. Soc.
2005, 127, 15949.
16. (a) Tanaka, F.; Mase, N.; Barbas, C. F., III. Chem. Commun. 2004, 1762; (b) Wang,
W. H.; Escobedo, J. O.; Lawrence, C. M.; Strongin, R. M. J. Am. Chem. Soc. 2004,
126, 340; (c) Zhang, M.; Li, M.; Zh, Q.; Li, F.; Zhang, D.; Zhang, J.; Huang, C.
Tetrahedron Lett. 2007, 48, 2329; (d) Shao, N.; Jin, J.; Cheung, S.; Yang, R.; Chan,
W.; Mo, T. Angew. Chem., Int. Ed. 2006, 45, 4944.
17. (a) Shibata, A.; Furukawa, K.; Abe, H.; Tsunedab, S.; Itoa, Y. Bioorg. Med. Chem.
Lett. 2008, 18, 2246; (b) Zhang, M.; Yu, M.; Li, F.; Zhu, M.; Li, M.; Gao, Y.; Li, L.;
Liu, Z.; Zhang, J.; Zhang, D.; Yi, T.; Huang, C. J. Am. Chem. Soc. 2007, 129, 10322.
18. (a) Tolbert, T. J.; Wong, C.-H. Angew. Chem., Int. Ed. 2002, 41, 2171; (b)
Fourneau, J. P.; Efimovsky, O.; Gaignault, J. C.; Jacquier, R.; LeRidant, C. C.R.
Acad. Sci. Ser. C 1971, 272, 1982; (c) Cooper, A. J. L.; Meinster, A. J. Biol. Chem.
1982, 257, 816.
(KBr) v: 2950, 1695, 1647, 1630, 1560, 1430, 1280, 1150, 1035 cmꢁ1 1H NMR
.
(CDCl3, 400 MHz) d 0.985 (t, J = 7.2 Hz, 3H), 1.42–1.47 (m, 2H), 1.69–1.75 (m,
2H), 4.16 (t, J = 7.2 Hz, 2H), 8.18 (d, J = 8.0 Hz, 1H), 8.25 (d, J = 8.0 Hz, 1H), 8.41
(d, J = 8 Hz, 1H), 8.72 (d, J = 8.0 Hz, 1H). 13C NMR (CDCl3, 100 MHz) d 13.83,
20.29, 30.20, 40.36, 107.12, 125.87, 126.67, 128.99, 135.28, 136.66, 136.87,
139.15, 139.87, 141.65, 161.56, 163.86. MS (ESI) C16H13BrINO2 [M+H+]: 457.9.
22. The preparation of N-butyl-4,5-(p-aldehyde)phenyl-1,8-naphthalimide (1): To a
solution of 46 mg (0.1 mmol) N-butyl-4-bromo-5-iodo-1,8-naphthalimide in
10 mL toluene under dry N2, 45 mg (0.3 mmol) p-aldehydephenylboric acid
and catalytic amounts of Pd(PPh3)4 were added. The mixture was then heated
at reflux for 6 h at 110 °C and monitored by TLC. After the reaction was
completed, the solvent was removed under reduced pressure. The crude
product was then purified by column chromatography (SiO2, CHCl3) to give 1
as
a
white solid in 90% yield (40 mg). Mp 174–175 °C, 1H NMR (CDCl3,
400 MHz) d 1.04 (t, J = 7.2 Hz, 3H), 1.47–1.55 (m, 2H), 1.75–1.82 (m, 2H), 4.26
(t, J = 7.2 Hz, 2H), 7.20 (d, J = 8.0 Hz, 4H), 7.52 (d, J = 8.0 Hz, 4H), 7.73 (d,
J = 7.8 Hz, 2H), 8.76 (d, J = 7.8 Hz, 2H), 9.83 (s, 2H). 13C NMR (CDCl3, 100 MHz) d
13.83, 20.39, 30.20, 40.46, 123.12, 127.57, 128.99, 130.20, 130.36, 130.77,
131.65, 134.87, 145.15, 147.24, 163.86, 191.13. HRMS (ESI) calcd for C30H23NO4
[M+Na+]: 484.1511, found: 484.1511.
19. Xu, Z.; Xiao, Y.; Qian, X.; Cui, J.; Cui, D. Org. Lett. 2005, 7, 889.
20. Preparation of N-butyl-4-bromo-5-amino-1.8-naphthalimide (3): Compound 2
(3.76 g, 0.01 mol) was added to a previously prepared solution of glacial acetic
acid (40 ml) containing 15.3 g of SnCl2 (0.08 mmol) and aerated with hydrogen
chloride. The reaction mixture was stirred for 1 h. The precipitated solid was